Stockreport

OS Therapies to Participate in Spotlight Panel at BioFuture 2025 October 13 11:00am EDT [Yahoo! Finance]

OS Therapies Incorporated  (OSTX) 
PDF clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced that it has been invited to participate in the "Beyond the Cure: T [Read more]